Astellas Pharma Inc. (4503) - Financials, balance sheet (quarterly)

1,390.5 JPY

10.5

0.76%

Last update May 22, 3:24 PM JST

Main market

Day range

1,390.5

1,373

1,396

Previous close

1,380

Open

1,374

Access this stock data via API

Astellas Pharma Inc.

1,390.50

10.50

0.76%

Financials

Balance sheet

Fiscal date	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total assets	3.6T	3.4T	3.5T	2.8T
Current assets	1.2T	1.1T	1.1T	1.3T
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	335.7B	254.0B	334.0B	561.5B
Other short term investments	28.8B	31.5B	29.7B	41.3B
Accounts receivable	535.0B	496.0B	487.9B	462.5B
Other receivables	—	—	—	—
Inventory	248.7B	226.0B	213.6B	200.2B
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	1.2B	1.2B	1.2B	1.2B
Hedging assets	—	—	—	—
Other current assets	32.2B	31.6B	33.7B	36.0B
Non current assets	2.4T	2.3T	2.4T	1.5T
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	2.3T	2.2T	2.3T	1.3T
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.5T	1.5T	1.5T	590.4B
Investments and advances	—	—	—	—
Other non current assets	18.6B	8.6B	8.7B	9.5B
Total liabilities	2.0T	1.9T	1.9T	1.2T
Current liabilities	1.3T	1.2T	1.2T	991.5B
Accounts payable	185.2B	150.4B	147.3B	138.4B
Accrued expenses	—	—	—	—
Short term debt	472.3B	407.2B	416.6B	309B
Deferred revenue	—	—	—	—
Tax payable	38.5B	34.8B	31.3B	16.3B
Pensions	—	—	—	—
Other current liabilities	476.5B	446.8B	455.8B	410.2B
Non current liabilities	687.9B	711.7B	741.4B	228.0B
Long term provisions	7.4B	5.4B	5.4B	9.6B
Long term debt	447.7B	463.8B	473.1B	50B
Provision for risks and charges	2.2B	2.2B	2.3B	2.4B
Deferred liabilities	51.3B	70.0B	92.7B	6.5B
Derivative product liabilities	—	—	—	—
Other non current liabilities	49.0B	44.1B	42.7B	39.6B
Shareholders equity
Common stock	103.0B	103.0B	103.0B	103.0B
Retained earnings	809.4B	838.6B	884.5B	884.5B
Other shareholders equity	—	—	—	—
Total shareholders equity	1.6T	1.5T	1.6T	1.6T
Additional paid in capital	184.1B	183.0B	182.1B	180.6B
Treasury stock	33.8B	34.1B	34.4B	34.5B
Minority interest	—	—	—	—